
Publication|Videos|July 31, 2023
Deep Dive into the Use of Real-World Registry Data as External Control Arms
Author(s)CorEvitas
While clinical registries are a valued source of longitudinal, real-world data, registries also provide expanded options for research and advancing randomized clinical trials. Understanding when and how to use registries in these use cases is quite nuanced and mandates a targeted approach and innovative expertise. In this video, we dive deep into the expanded use of registries as external control arms in clinical trials.
Advertisement
Watch this video and learn more:
- Challenges faced by biopharma companies conducting clinical trials when studying rare conditions.
- The purpose of a control population in traditional randomized controlled clinical trials.
- How hybrid control arms can improve the strength of control groups.
- How prospective registries serve as real-world control populations.
- How to minimize bias between populations or outcome measures across RCT control groups vs. real-world/hybrid controls.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
The Business Case for Employer-Based GLP-1 Coverage
5




